vs

Side-by-side financial comparison of NeuroPace Inc (NPCE) and TEJON RANCH CO (TRC). Click either name above to swap in a different company.

NeuroPace Inc is the larger business by last-quarter revenue ($26.6M vs $21.1M, roughly 1.3× TEJON RANCH CO). TEJON RANCH CO runs the higher net margin — 7.5% vs -10.3%, a 17.8% gap on every dollar of revenue. On growth, NeuroPace Inc posted the faster year-over-year revenue change (23.9% vs 17.7%). Over the past eight quarters, TEJON RANCH CO's revenue compounded faster (68.8% CAGR vs 21.1%).

NeuroPace Inc is a medical technology company focused on developing and commercializing innovative implantable neurostimulation systems to treat neurological disorders, primarily drug-resistant epilepsy. Its core RNS System delivers personalized responsive stimulation to reduce seizure frequency, serving patients across North America and select global markets via partnerships with healthcare providers.

Tejon Ranch Company, based in Lebec, California, is one of the largest private landowners in California. The company was incorporated in 1936 to organize the ownership of a large tract of land that was consolidated from four Mexican land grants acquired in the 1850s and 1860s by ranch founder Edward Fitzgerald Beale.

NPCE vs TRC — Head-to-Head

Bigger by revenue
NPCE
NPCE
1.3× larger
NPCE
$26.6M
$21.1M
TRC
Growing faster (revenue YoY)
NPCE
NPCE
+6.2% gap
NPCE
23.9%
17.7%
TRC
Higher net margin
TRC
TRC
17.8% more per $
TRC
7.5%
-10.3%
NPCE
Faster 2-yr revenue CAGR
TRC
TRC
Annualised
TRC
68.8%
21.1%
NPCE

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
NPCE
NPCE
TRC
TRC
Revenue
$26.6M
$21.1M
Net Profit
$-2.7M
$1.6M
Gross Margin
77.4%
30.6%
Operating Margin
-6.6%
10.9%
Net Margin
-10.3%
7.5%
Revenue YoY
23.9%
17.7%
Net Profit YoY
48.0%
-64.7%
EPS (diluted)
$-0.08
$0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NPCE
NPCE
TRC
TRC
Q4 25
$26.6M
$21.1M
Q3 25
$27.4M
$12.0M
Q2 25
$23.5M
$8.3M
Q1 25
$22.5M
$8.2M
Q4 24
$21.5M
$17.9M
Q3 24
$21.1M
$10.9M
Q2 24
$19.3M
$5.7M
Q1 24
$18.1M
$7.4M
Net Profit
NPCE
NPCE
TRC
TRC
Q4 25
$-2.7M
$1.6M
Q3 25
$-3.5M
$1.7M
Q2 25
$-8.7M
$-1.7M
Q1 25
$-6.6M
$-1.5M
Q4 24
$-5.3M
$4.5M
Q3 24
$-5.5M
$-1.8M
Q2 24
$-7.5M
$957.0K
Q1 24
$-8.9M
$-914.0K
Gross Margin
NPCE
NPCE
TRC
TRC
Q4 25
77.4%
30.6%
Q3 25
77.4%
28.4%
Q2 25
77.1%
40.9%
Q1 25
77.0%
15.0%
Q4 24
75.4%
42.9%
Q3 24
73.2%
22.9%
Q2 24
73.4%
45.3%
Q1 24
73.6%
0.3%
Operating Margin
NPCE
NPCE
TRC
TRC
Q4 25
-6.6%
10.9%
Q3 25
-9.5%
-16.9%
Q2 25
-29.0%
-48.8%
Q1 25
-22.9%
-50.7%
Q4 24
-17.0%
11.9%
Q3 24
-20.1%
-34.9%
Q2 24
-32.4%
-62.4%
Q1 24
-41.6%
-53.8%
Net Margin
NPCE
NPCE
TRC
TRC
Q4 25
-10.3%
7.5%
Q3 25
-12.8%
14.0%
Q2 25
-36.8%
-20.6%
Q1 25
-29.3%
-17.8%
Q4 24
-24.5%
25.0%
Q3 24
-25.9%
-16.9%
Q2 24
-39.0%
16.8%
Q1 24
-49.2%
-12.3%
EPS (diluted)
NPCE
NPCE
TRC
TRC
Q4 25
$-0.08
$0.05
Q3 25
$-0.11
$0.06
Q2 25
$-0.26
$-0.06
Q1 25
$-0.21
$-0.05
Q4 24
$-0.16
$0.16
Q3 24
$-0.19
$-0.07
Q2 24
$-0.26
$0.04
Q1 24
$-0.32
$-0.03

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
NPCE
NPCE
TRC
TRC
Cash + ST InvestmentsLiquidity on hand
$61.1M
$9.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$19.0M
$475.2M
Total Assets
$105.6M
$630.5M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
NPCE
NPCE
TRC
TRC
Q4 25
$61.1M
$9.5M
Q3 25
$60.0M
$3.6M
Q2 25
$62.1M
$2.5M
Q1 25
$66.3M
$12.3M
Q4 24
$52.8M
$39.3M
Q3 24
$56.8M
$27.4M
Q2 24
$55.5M
$33.0M
Q1 24
$58.9M
$35.6M
Stockholders' Equity
NPCE
NPCE
TRC
TRC
Q4 25
$19.0M
$475.2M
Q3 25
$18.5M
$473.2M
Q2 25
$19.4M
$471.5M
Q1 25
$24.3M
$472.5M
Q4 24
$8.0M
$473.6M
Q3 24
$9.8M
$468.3M
Q2 24
$9.9M
$469.2M
Q1 24
$14.3M
$467.4M
Total Assets
NPCE
NPCE
TRC
TRC
Q4 25
$105.6M
$630.5M
Q3 25
$107.3M
$629.6M
Q2 25
$106.1M
$618.5M
Q1 25
$110.2M
$614.6M
Q4 24
$94.6M
$608.0M
Q3 24
$96.3M
$598.0M
Q2 24
$94.4M
$590.8M
Q1 24
$98.9M
$581.6M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
NPCE
NPCE
TRC
TRC
Operating Cash FlowLast quarter
$506.0K
$6.1M
Free Cash FlowOCF − Capex
$409.0K
FCF MarginFCF / Revenue
1.5%
Capex IntensityCapex / Revenue
0.4%
Cash ConversionOCF / Net Profit
3.88×
TTM Free Cash FlowTrailing 4 quarters
$-11.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
NPCE
NPCE
TRC
TRC
Q4 25
$506.0K
$6.1M
Q3 25
$-1.9M
$-2.4M
Q2 25
$-2.1M
$-381.0K
Q1 25
$-7.5M
$-1.3M
Q4 24
$-4.8M
$14.3M
Q3 24
$-1.7M
$2.1M
Q2 24
$-3.9M
$-1.8M
Q1 24
$-7.5M
$777.0K
Free Cash Flow
NPCE
NPCE
TRC
TRC
Q4 25
$409.0K
Q3 25
$-2.0M
$-14.6M
Q2 25
$-2.3M
$-20.0M
Q1 25
$-7.5M
$-18.9M
Q4 24
$-4.8M
$-42.9M
Q3 24
$-1.8M
$-16.8M
Q2 24
$-4.0M
$-15.8M
Q1 24
$-7.6M
$-7.3M
FCF Margin
NPCE
NPCE
TRC
TRC
Q4 25
1.5%
Q3 25
-7.2%
-122.2%
Q2 25
-9.6%
-240.6%
Q1 25
-33.4%
-230.1%
Q4 24
-22.5%
-239.3%
Q3 24
-8.7%
-155.2%
Q2 24
-20.6%
-277.2%
Q1 24
-42.1%
-99.0%
Capex Intensity
NPCE
NPCE
TRC
TRC
Q4 25
0.4%
Q3 25
0.1%
102.3%
Q2 25
0.7%
236.0%
Q1 25
0.2%
213.7%
Q4 24
0.2%
319.1%
Q3 24
0.5%
174.3%
Q2 24
0.3%
245.5%
Q1 24
0.6%
109.5%
Cash Conversion
NPCE
NPCE
TRC
TRC
Q4 25
3.88×
Q3 25
-1.43×
Q2 25
Q1 25
Q4 24
3.19×
Q3 24
Q2 24
-1.88×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons